Highlights –
- Philippines begin clinical trials of the Japanese anti-flu drug Avigan to treat COVID-19.
- The trial is set for a period of 90 days at present.
- The clinical trials will be held in just four hospitals in Metro Manila at present.
- Avigan is an antiviral drug manufactured by a subsidiary of Fujifilm Holdings Corp.
Japan’s antiviral drug A....
Tags : JAPAN, PHILIPPINES, ANTIVIRAL DRUG, AVIGAN, FUJIFILM HOLDINGS CORP., COVID-19 TREATMENT, COVID-19, CLINICAL TRIAL OF AVIGAN,
comments (0)